1. Enhanced drug release from a pH-responsive nanocarrier can augment colon cancer treatment by blocking PD-L1 checkpoint and consuming tumor glucose;Guo;Mater. Design,2022
2. CRISPR/Cas9 screening: unraveling cancer immunotherapy’s ‘Rosetta Stone’;Chen;Trends Mol. Med.,2024
3. Targeting metabolic circuitry to supercharge CD8+ T cell antitumor responses;Cai;Cell Metab.,2024
4. Manipulation of immune–vascular crosstalk: new strategies towards cancer treatment;Zhao;Acta Pharm. Sin. B,2020
5. Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis;Trougakos;Trends Mol. Med.,2022